Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma
Clinical trial NCT02309580 · COMPLETED
Trial details
- NCT number
- NCT02309580
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2023-05-08
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.